NCT02742883View on ClinicalTrials.gov

A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG)

PHASE2SuspendedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

April 13, 2016

Primary Completion Date

March 31, 2028

Study Completion Date

March 31, 2028

Conditions
Diffuse, Intrinsic Pontine Glioma
Interventions
DRUG

Antineoplaston therapy (Atengenal + Astugenal)

Patients with diffuse intrinsic pontine glioma will receive Antineoplaston therapy (Atengenal + Astugenal).

Trial Locations (1)

77055-6330

Burzynski Clinic, Houston

Sponsors
All Listed Sponsors
lead

Burzynski Research Institute

OTHER